<DOC>
	<DOCNO>NCT00694746</DOCNO>
	<brief_summary>This trial provide preliminary data test hypothesis six-month treatment period fish oil overweight adolescent mild moderate persistent elevation ALT level presence hepatic steatosis CT-scan safe result decrease ALT .</brief_summary>
	<brief_title>Study Fish Oil Reduce ALT Levels Adolescents</brief_title>
	<detailed_description>Over past two decade , pre-adult nonalcoholic fatty liver disease ( NAFLD ) emerge relative obscurity become common cause liver disease pediatric patient . Currently , 17 % US child adolescent BMI great 95th percentile age gender 20 % child weight management program estimate NAFLD . Untreated NAFLD lead fibrosis establish cirrhosis child young 10 . Fish oil rich source omega-3-acid ethyl ester n-3 long-chain polyunsaturated fatty acid , increase evidence suggest may safely improve hepatic steatosis . Given prevalence obesity , NAFLD , severe , progressive nature condition , effective treatment strategy urgently need . We plan gather preliminary data efficacy safety fish oil supplement reduce persistent elevation ALT level hepatic steatosis abdominal CT-scan among urban youth ( BMI &gt; =95th percentile ) . This preliminary data provide necessary information calculate sample size phase 2 trial .</detailed_description>
	<mesh_term>Liver Diseases</mesh_term>
	<mesh_term>Fatty Liver</mesh_term>
	<mesh_term>Non-alcoholic Fatty Liver Disease</mesh_term>
	<criteria>BMI ( kg/m2 ) 95th percentile age gender Weight 400 pound ( less 182 kilogram ) Persistent elevation ALT ( 4190 UI/L study screen ) Presence hepatic steatosis abdominal CTscan Able give inform consent/assent Type 2 diabetes mellitus Prior drug treatment diabetes , insulin insensitivity , weight loss medication six month screen Use prescription strength glucocorticoid within three month screen History syndrome medical disorder associate significant obesity Participation weight loss program within six month screen result 5 % weight loss History weight loss surgery Alcohol use twice weekly 3 alcohol containing beverage within 24hour period past six month Known suspected bleed condition History liver disease include prior liver biopsy NASH type 2 cirrhosis Former present positive blood test Infectious hepatitis B C , autoimmune hepatitis , Wilson disease , Alpha1 antitrypsin deficiency , Iron storage disease , high TSH History past current pregnancy Use illegal/illicit drug Other condition contraindicate cause caution use fish oil Unable comply protocol Any serious disease determine study gastroenterologist physician nutrition specialist potential study risk patient</criteria>
	<gender>All</gender>
	<minimum_age>13 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>ALT</keyword>
	<keyword>Non-Alcoholic Fatty Liver Disease</keyword>
	<keyword>Adolescents</keyword>
	<keyword>Overweight</keyword>
	<keyword>Treatment</keyword>
</DOC>